Bifunctional cysteine gold nanocluster for β-amyloid fibril inhibition and fluorescence imaging: A distinctive approach to manage Alzheimer's disease

Simple item page
dc.contributor.authorResmi, AN
dc.contributor.authorRekha, CR
dc.contributor.authorDhushyandhun, ME
dc.contributor.authorSarathkumar, E
dc.contributor.authorShenoy, SJ
dc.contributor.authorGulia, KK
dc.contributor.authorJayasree, RS
dc.date.accessioned2023-06-05T08:14:12Z
dc.date.available2023-06-05T08:14:12Z
dc.date.issued2023-04
dc.description.abstractAlzheimer's disease (AD) is a progressive complex neurodegenerative disorder affecting millions of individuals worldwide. Currently, there is no effective treatment for AD. AD is characterized by the deposition of amyloid plaques/fibrils. One major strategy for managing this disease is by slowing the progression of AD using different drugs which could potentially limit free-radical formation, oxidative stress and lipid peroxidation and promote the survival of neurons exposed to β-amyloid. Inhibition of amyloid fibrillization and clearance of amyloid plaques/fibrils are essential for the prevention and treatment of AD. The thiophilic interaction between the side chain of an aromatic residue in a polypeptide and a sulphur atom of the compound can effectively inhibit amyloid fibril formation. In this work, we have synthesized cysteine-capped gold nanoclusters (Cy-AuNCs) which exhibit inherent red emission and can disintegrate amyloid fibrils through the aforementioned thiophilic interactions. Herein, we also used molecular docking to study the thiophilic interactions between the sulphur atom of Cy-AuNCs and the aromatic rings of the protein. Finally, the gold cluster was functionalized with a brain targeting molecule, Levodopa (AuCs-LD), to specifically target the brain and to facilitate passage through the blood brain barrier (BBB). Both Cy-AuNCs and AuCs-LD showed good biocompatibility and the inherent fluorescence properties of nanoclusters enabled real time imaging. The efficacy of the nanoclusters to disintegrate amyloid fibrils and their ability to cross the BBB were demonstrated both in vitro and in vivo in the BBB model and the AD animal model respectively. Our results imply that nanoparticle-based artificial molecular chaperones may offer a promising therapeutic approach for AD.en_US
dc.identifier.citationResmi AN, Rekha CR,.Dhushyandhun ME, Sarathkumar E, Shenoy SJ, Gulia KK, Jayasree RS. Bifunctional cysteine gold nanocluster for β-amyloid fibril inhibition and fluorescence imaging: A distinctive approach to manage Alzheimer's disease. Journal of Materials Chemistry B. 2023;11:4715-4724en_US
dc.identifier.uriDOI https://doi.org/10.1039/D2TB02802F
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/11271
dc.publisherJournal of Materials Chemistry Ben_US
dc.titleBifunctional cysteine gold nanocluster for β-amyloid fibril inhibition and fluorescence imaging: A distinctive approach to manage Alzheimer's diseaseen_US
dc.typeArticleen_US
Files
Collections
Journal Articles